Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Infections in Pediatric Cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2009 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00930267
First received: June 28, 2009
Last updated: June 29, 2009
Last verified: June 2009

June 28, 2009
June 29, 2009
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00930267 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Infections in Pediatric Cancer Patients
Epidemiology and Etiology of Infections in Pediatric Cancer Patients: A Prospective Study

A prospective epidemiological study conducted in pediatric hematology oncology center in Hadassah medical center. The study will include all newly diagnosed pediatric cancer patients age 0-18 years admitted with fever during chemotherapy.

In each event of febrile episode during chemotherapy, the following data will be collected using a patient data form and computerized software.

Demographic data: age, gender, ethnicity. Clinical data: Underlying disease, immunizations, prophylactic antibiotics, presence of central venous catheter, intensity of chemotherapy, duration of fever, duration and severity of neutropenia, diagnosis of present event.

Imaging data Microbiological data Outcome The statistical analysis will be performed by an epidemiologist and statistician using the SPSS 12.0 software.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

All newly diagnosed pediatric cancer patients age 0-18 years admitted with fever during or following chemotherapy

Infections
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Pediatric cancer patients age 0-18 years admitted with fever during or following chemotherapy

Exclusion Criteria:

  • No exclusions
Both
up to 18 Years
No
Contact: Arik Tzukert, DMD 00 972 2 6776095 arik@hadassah.org.il
Contact: Hadas Lemberg, PhD 00 972 2 6777572 lhadas@hadassah.org.il
Not Provided
 
NCT00930267
yael12-HMO-CTIL
Not Provided
Not Provided
Hadassah Medical Organization
Not Provided
Principal Investigator: Dan Engelhard, MD Hadassah Medical Center
Principal Investigator: Diana Averbuch, MD Hadassah Medical Center
Hadassah Medical Organization
June 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP